Showing 1181-1190 of 5128 results for "".
- Online Extra: Let’s Talk About Truncal Acnehttps://practicaldermatology.com/news/online-extra-lets-talk-about-truncal-acne/2461304/While often trivialized as a cosmetic skin disease, acne is in fact an inflammatory skin condition with a complex pathogenesis associated with a significant physical and psychological burden. Approximately 50% of people with facial acne also have truncal acne manifesting on the back, shoulders, a
- CDC: People with Acne, AD, PsO, and Other Active Exfoliative Skin Conditions at Higher Risk for Severe Monkeypoxhttps://practicaldermatology.com/news/cdc-people-with-acne-ad-pso-and-other-active-exfoliative-skin-conditions-at-higher-risk-for-severe-monkeypox/2461303/People with active exfoliative skin conditions are at higher risk for severe Monkeypox, according to interim clinical guidance from the federal Centers for Disease Control and Prevention. Many people infected with monkeypox virus have a
- Researchers Discover New Approach to Healing Skin Infections, Woundshttps://practicaldermatology.com/news/researchers-discover-new-approach-to-healing-skin-infections-wounds/2461302/New research may lead to advancements in treating bacterial infections and wounds. Monocytes alone are capable of facilitating faster healing of wounds. Monocytes help the healing process by regulating leptin levels and blood vessel growth during wound repair. They also produce ghrelin,
- Lilly's Taltz Now Available in Citrate-Free Formulationhttps://practicaldermatology.com/news/lillys-taltz-now-available-in-citrate-free-formulation/2461291/Lilly's Taltz® (ixekizumab) is now available in a new, citrate-free formulation to reduce injection site pain. The new formulation, which was recently approved by The U.S. Food and Drug Administration in May 2022, includes the same active ingredient as the original formula
- NRS Survey: Persistent Facial Redness Named Most Common and Bothersome Sign of Rosaceahttps://practicaldermatology.com/news/nrs-survey-persistent-facial-redness-is-the-most-common-and-bothersome-sign-of-rosacea/2461285/The great majority of rosacea patients have experienced persistent facial redness, and most of them report it is the most frequently bothersome sign they face, according to a recent National Rosacea Society (NRS) survey on rosacea redness sponsored by EPI Health. Furthermore, two-
- DermTech Appoints Two New Board Membershttps://practicaldermatology.com/news/dermtech-appoints-two-new-board-members/2461272/DermTech, Inc. appointed Kirk D. Malloy, Ph.D. and Mark C. Capone, M.S. to the Company’s board of directors, effective July 18,2022. These appointments expand DermTech’s board of directors to eight members. “We are excited to welco
- Health Canada Clears Cutera’s AviClearhttps://practicaldermatology.com/news/health-canada-clears-cuteras-aviclear/2461268/Health Canada has cleared Cutera, Inc.’s AviClear for the treatment of mild, moderate, and severe acne. This Health Canada announcement comes on the heels of the U.S. Food and Drug Administration’s 510(k) clearance of AviClear, in March 2022. In addition
- Dial Joins Forces with DonorsChoose and TeacherLists to Support Teachershttps://practicaldermatology.com/news/dial-joins-forces-with-donorschoose-and-teacherlists-to-supoort-teachers/2461264/Dial is doubling down on efforts to support teachers with a back-to-school marketing campaign. For the second year in a row, Dial has partnered with
- Crown CFO to Take on COO Role Toohttps://practicaldermatology.com/news/crown-cfo-to-take-on-coo-role-too/2461259/Crown Laboratories Chief Financial Officer (CFO) Nadeem Moiz will take on expanded responsibilities as Chief Operations Officer (COO). This appointment is made as Jack Songster, Crown's current COO, is set to retire on July 15. In this dual role, Mr. Moiz w
- NYC PrideFest: Galderma Aesthetics to Participatehttps://practicaldermatology.com/news/nyc-pridefest-galderma-aesthetics-to-participate/2461249/Galderma is participating in New York City's official LGBTQIA+ Pride (NYC Pride) event. This month marks the official launch of Restylane's "XpresYourself" communications campaign, which gives a nod to Restylane's XpresHAn Technology™, a u